Manuscripts and Publications

Filters: Keyword is Medication Adherence  [Clear All Filters]
Publication
Belzer ME, MacDonell KKolmodin, Clark LF, Huang J, Olson J, Kahana SY, Naar S, Sarr M, Thornton S.  2015.  Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.. AIDS Patient Care STDS. 29(6):338-45.
Philbin MM, Tanner AE, Ma A, Chambers BD, Ware S, Kinnard EN, Hussen SA, Lee S, J Fortenberry D.  2017.  Adolescent and Adult HIV Providers' Definitions of HIV-Infected Youths' Successful Transition to Adult Care in the United States.. AIDS Patient Care STDS. 31(10):421-427.
MacDonell K, Naar-King S, Huszti H, Belzer M.  2013.  Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.. AIDS Behav. 17(1):86-93.
Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MIsabel, Rubin D.  2016.  Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked To and Engaged in Medical Care.. LGBT Health. 3(2):162-7.
Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, Hosek S.  2019.  Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.. J Acquir Immune Defic Syndr. 80(2):160-165.
Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P et al..  2018.  Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.. Clin Infect Dis. 66(2):213-219.
Saberi P, Mayer K, Vittinghoff E, Naar-King S.  2015.  Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.. AIDS Behav. 19(1):93-103.
Tanney MR, Naar-King S, MacDonnel K.  2012.  Depression and stigma in high-risk youth living with HIV: a multi-site study.. J Pediatr Health Care. 26(4):300-5.
Brown LK, Kennard BD, Emslie GJ, Mayes TL, Whiteley LB, Bethel J, Xu J, Thornton S, Tanney MR, Hawkins LA et al..  2016.  Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.. J Acquir Immune Defic Syndr. 71(1):38-46.
Castillo-Mancilla J, Seifert S, Campbell K, Coleman S, McAllister K, Zheng J-H, Gardner EM, Liu A, Glidden DV, Grant R et al..  2016.  Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.. Antimicrob Agents Chemother. 60(11):6692-6697.
Murphy DA, Lam P, Naar-King S, D Harris R, Parsons JT, Muenz LR.  2010.  Health literacy and antiretroviral adherence among HIV-infected adolescents.. Patient Educ Couns. 79(1):25-9.
Tanner AE, Philbin MM, Chambers BD, Ma A, Hussen S, Ware S, Lee S, J Fortenberry D.  2018.  Healthcare Transition for Youth Living With HIV: Outcomes from a Prospective Multi-site Study.. J Adolesc Health. 63(2):157-165.
Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Mulligan K, Zimet G et al..  2017.  An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.. J Acquir Immune Defic Syndr. 74(1):21-29.
Sayegh CS, MacDonell KK, Clark LF, Dowshen NL, Naar S, Olson-Kennedy J, van den Berg JJ, Xu J, Belzer M.  2018.  The Impact of Cell Phone Support on Psychosocial Outcomes for Youth Living with HIV Nonadherent to Antiretroviral Therapy.. AIDS Behav. 22(10):3357-3362.
Martinez J, Harper G, Carleton RA, Hosek S, Bojan K, Clum G, Glum G, Ellen J.  2012.  The impact of stigma on medication adherence among HIV-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care.. AIDS Patient Care STDS. 26(2):108-15.
Sullivan PS, Mena L, Elopre L, Siegler AJ.  2019.  Implementation Strategies to Increase PrEP Uptake in the South.. Curr HIV/AIDS Rep. 16(4):259-269.
Outlaw AY, Naar-King S, Tanney M, Belzer ME, Aagenes A, Parsons JT, Merlo LJ.  2014.  The initial feasibility of a computer-based motivational intervention for adherence for youth newly recommended to start antiretroviral treatment.. AIDS Care. 26(1):130-5.
Naar-King S, Outlaw AY, Sarr M, Parsons JT, Belzer M, MacDonell K, Tanney M, Ondersma SJ.  2013.  Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment.. J Pediatr Psychol. 38(6):638-48.
Dinaj-Koci V, Wang B, Naar-King S, MacDonell KKolmodin.  2019.  A Multi-Site Study of Social Cognitive Factors Related to Adherence Among Youth Living With HIV in the New Era of Antiretroviral Medication.. J Pediatr Psychol. 44(1):98-109.
Coy KC, Hazen RJ, Kirkham HS, Delpino A, Siegler AJ.  2019.  Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.. J Int AIDS Soc. 22(2):e25252.
Gross IMoses, Hosek S, Richards MHeather, M Fernández I.  2016.  Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.. AIDS Patient Care STDS. 30(7):324-38.
Macdonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW.  2010.  Predictors of medication adherence in high risk youth of color living with HIV.. J Pediatr Psychol. 35(6):593-601.
Baker Z, Javanbakht M, Mierzwa S, Pavel C, Lally M, Zimet G, Gorbach P.  2018.  Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data.. AIDS Behav. 22(4):1174-1183.
MacDonell KKolmodin, Jacques-Tiura AJ, Naar S, Fernandez MIsabella.  2016.  Predictors of Self-Reported Adherence to Antiretroviral Medication in a Multisite Study of Ethnic and Racial Minority HIV-Positive Youth.. J Pediatr Psychol. 41(4):419-28.
Hosek SG, Harper GW, Lemos D, Burke-Miller J, Lee S, Friedman L, Martinez J.  2018.  Project ACCEPT: Evaluation of a Group-Based Intervention to Improve Engagement in Care for Youth Newly Diagnosed with HIV.. AIDS Behav. 22(8):2650-2661.
Kahana SY, Fernandez MIsabel, Wilson PA, Bauermeister JA, Lee S, Wilson CM, Hightow-Weidman LB.  2015.  Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.. J Acquir Immune Defic Syndr. 68(2):169-77.
Muessig KE, LeGrand S, Horvath KJ, Bauermeister JA, Hightow-Weidman LB.  2017.  Recent mobile health interventions to support medication adherence among HIV-positive MSM.. Curr Opin HIV AIDS. 12(5):432-441.
Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, D Harris R, Mulligan K, Zimet G et al..  2017.  Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.. JAMA Pediatr. 171(11):1063-1071.
Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, Gaur AH, Clark LF.  2014.  The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial.. AIDS Behav. 18(4):686-96.
Nugent NR, Brown LK, Belzer M, Harper GW, Nachman S, Naar-King S.  2010.  Youth living with HIV and problem substance use: elevated distress is associated with nonadherence and sexual risk.. J Int Assoc Physicians AIDS Care (Chic). 9(2):113-5.